Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
MSKCC study of 308 pts w/ smoldering myeloma finds lower risk of progression vs. historical reports w/ annual PD rate of ∼6.8% in 1st 5 years; high risk pts by 2/20/20 model had 2- and 5-year progression risks of 35% and 67%.”
Title: Prognosis and patterns of progression in smoldering multiple myeloma
Authors: Theresia Akhlaghi, Kylee H. Maclachlan, Adriana Wiggins, Saad Z. Usmani,
Andriy Derkach, Malin Hultcrantz
You can read the Full Article in Blood Advances.
You can find other articles featuring Robert Z. Orlowski on OncoDaily.
